Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Neerman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Anti-Cancer Drugs|June 22, 2007
The efficiency of a PAMAM dendrimer toward the encapsulation of the antileukemic drug 6-mercaptopurineMichael F Neerman
Pharmacological Research|May 14, 2003
A possible mechanism of gastrointestinal toxicity posed by mycophenolic acidMichael F Neerman, Dawn M Boothe
Journal of Forensic Sciences|October 23, 2012
A drug fatality involving KratomMichael F Neerman, Randall E Frost, Janine Deking
Journal of Emergency Nursing|July 24, 2007
Ethylene glycol poisoning: current diagnostic and management issuesLarissa I Velez, Rebeca Gracia, Michael F Neerman
Clinical Pediatrics|June 5, 2010
A dispensing error resulting in possible fluoxetine overdose and subsequent discontinuation syndrome in a childLarissa I Velez, Sing-Yi Feng, Michael F Neerman
The American Journal of Forensic Medicine and Pathology|December 21, 2011
Postmortem atropine concentrations in resuscitation casesD Kimberley Molina, Michael F Neerman, Sarah A Wilk
International Journal of Pharmaceutics|August 4, 2004
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug deliveryMichael F Neerman, Wen Zhang, Alan R Parrish, et al.
Journal of the American Chemical Society|August 12, 2004
Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug deliveryHui-Ting Chen, Michael F Neerman, Alan R Parrish, et al.
Molecular Pharmaceutics|July 20, 2005
Reduction of drug toxicity using dendrimers based on melamineMichael F Neerman, Hui-Ting Chen, Alan R Parrish, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Anti-Cancer Drugs|June 22, 2007
The efficiency of a PAMAM dendrimer toward the encapsulation of the antileukemic drug 6-mercaptopurineMichael F Neerman
Pharmacological Research|May 14, 2003
A possible mechanism of gastrointestinal toxicity posed by mycophenolic acidMichael F Neerman, Dawn M Boothe
Journal of Forensic Sciences|October 23, 2012
A drug fatality involving KratomMichael F Neerman, Randall E Frost, Janine Deking
Journal of Emergency Nursing|July 24, 2007
Ethylene glycol poisoning: current diagnostic and management issuesLarissa I Velez, Rebeca Gracia, Michael F Neerman
Clinical Pediatrics|June 5, 2010
A dispensing error resulting in possible fluoxetine overdose and subsequent discontinuation syndrome in a childLarissa I Velez, Sing-Yi Feng, Michael F Neerman
The American Journal of Forensic Medicine and Pathology|December 21, 2011
Postmortem atropine concentrations in resuscitation casesD Kimberley Molina, Michael F Neerman, Sarah A Wilk
International Journal of Pharmaceutics|August 4, 2004
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug deliveryMichael F Neerman, Wen Zhang, Alan R Parrish, et al.
Journal of the American Chemical Society|August 12, 2004
Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug deliveryHui-Ting Chen, Michael F Neerman, Alan R Parrish, et al.
Molecular Pharmaceutics|July 20, 2005
Reduction of drug toxicity using dendrimers based on melamineMichael F Neerman, Hui-Ting Chen, Alan R Parrish, et al.
Pageof 1